According to Halozyme Therapeutics's latest financial reports the company's current earnings (TTM) are HK$3.24 B. In 2023 the company made an earning of HK$2.71 B an increase over its 2022 earnings that were of HK$1.94 B.The earnings displayed on this page is the company's Pretax Income.